Malaria drug association with hemolytic anemia unclear

Malaria drug association with hemolytic anemia unclear
Artesunate, a drug used in the treatment of severe malaria, may or may not be associated with hemolytic anemia, so the U.S. Centers for Disease Control and Prevention recommends close monitoring of patients treated with the drug for four weeks after administration of the agent, according to a report published in the Jan. 11 issue of the CDC's Morbidity & Mortality Weekly Report.

(HealthDay)—Artesunate, a drug used in the treatment of severe malaria, may or may not be associated with hemolytic anemia, so the U.S. Centers for Disease Control and Prevention recommends close monitoring of patients treated with the drug for four weeks after administration of the agent, according to a report published in the Jan. 11 issue of the CDC's Morbidity & Mortality Weekly Report.

Melissa Briggs, M.D., of the CDC in Atlanta, and colleagues reviewed reports of delayed hemolytic anemia after treatment with artesunate over concern that there may be an association between the illness and treatment with the anti-malaria medication.

The researchers theorized that the hemolysis was more likely due to the pathogenesis of malaria than to treatment with artesunate, but noted that artesunate used in the United States is produced by the U.S. Army Medical Materiel Development Activity, whereas artesunate used outside the United States has a different origin. As a result, there might be a difference between artesunates produced in different locales.

"To better assess these possibilities, [the] CDC has amended the artesunate investigational new drug protocol and now recommends that persons treated for severe malaria with artesunate be followed for four weeks after treatment and evaluated for ," the authors write.

More information: Full Text

add to favorites email to friend print save as pdf

Related Stories

New combination malaria treatment equally effective

Apr 05, 2012

(HealthDay) -- Fixed-dose, combination pyronaridine-artesunate treatment is as effective as mefloquine plus artesunate in treating malaria infection, according to a study published in the April 5 issue of ...

Rectal artemisinins rapidly eliminate malarial parasites

Mar 28, 2008

Artemisinin-based suppositories can help ‘buy time’ for malaria patients who face a delay in accessing effective, injectable antimalarials, according to research published in the online open access journal BMC Infectious Di ...

Recommended for you

Families wait in agony for word on Ebola patients

1 hour ago

First the ring tone echoed outside the barbed-wire-topped walls of the Ebola clinic. Then came the wails of grief, as news spread that 31-year-old Rose Johnson was dead just days after she was brought here ...

China to open first high security bio laboratory

1 hour ago

China's first high-security biosafety laboratory will be ready for use by December, in a move hailed as a "crucial" moment in the fight against pathogens such as the Ebola virus, officials said Tuesday.

US Ebola labs, parts for clinic arrive in Liberia

2 hours ago

U.S. mobile Ebola labs should be up and running in Liberia this week, and American troops have broken ground for a field hospital, as the international community races to increase the ability to care for ...

Ebola-hit Liberia staring into the abyss

7 hours ago

With its collapsed health service, sick and poorly equipped security forces and broken economy, Ebola-hit Liberia finds itself on the brink of complete societal breakdown, experts warn.

Dallas hospital monitoring patient for Ebola

7 hours ago

A patient in a Dallas hospital is showing signs of the Ebola virus and is being kept in strict isolation with test results pending, hospital officials said Monday.

User comments